Skip to main content
SpringerLink
Log in

Umbilical Cord Blood Biochemical Cardiac Markers and Fetal Cardiac Function in Cases of IUGR

  • Original Paper
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

To evaluate umbilical cord blood creatine kinase MB (CK-MB), troponin T (TnT-hs), pro-brain natriuretic peptide (proBNP), ischaemia modified albumin (IMA) levels and fetal cardiac function in intrauterine growth retardation (IUGR). The study included 39 pregnant women with IUGR and 42 healthy pregnant women in control group. IUGR was diagnosed when estimated fetal weight was < 10 percentile. Fetal cardiac function was evaluated by ultrasound in the third trimester of pregnancy and compared with the control group. Umbilical cord blood biochemical test (CK-MB, TnT-hs, proBNP, IMA) results compared between the groups. In cardiac morphological evaluation, cardiothoracic index was higher, and the left sphericity index was lower in the IUGR group compared to the control group (p < 0.001, p = 0,018). Left myocardial performance index (MPI) was higher, and tricuspid and mitral annular plane systolic excursion (TAPSE and MAPSE) values were lower in the IUGR group than the control group (p = 0.035, p = 0.038 and p = 0.011 respectively). In IUGR group, only proBNP levels were increased compare to the control group in umbilical cord blood biochemical tests (p = 0.018). There was negative correalation between umbilical cord blood proBNP levels and MAPSE value (r = − 0,332, p = 0,002). We observed that IUGR was associated with fetal cardiac morphological changes and systolic dysfunction. Also, in IUGR group cord, blood proBNP level was increased and negatively correlated with MAPSE value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in the article.

Code availability

None.

References

  1. Kesavan K, Devaskar SU. Intrauterine growth restriction: postnatal monitoring and outcomes. Pediatr Clin North Am. 2019;66:403–23.

    Article  PubMed  Google Scholar 

  2. Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). Am J Obstet Gynecol. 2020;223:B2-17.

    Article  PubMed  Google Scholar 

  3. Zur RL, Kingdom JC, Parks WT, Hobson SR. The placental basis of fetal growth restriction. Obstet Gynecol Clin North Am. 2020;47:81–98.

    Article  PubMed  Google Scholar 

  4. Patey O, Carvalho JS, Thilaganathan B. Perinatal changes in cardiac geometry and function in growth-restricted fetuses at term. Ultrasound in Obstetrics & Gynecology : The Official J Int Soc Ultrasound in Obstetrics Gynecol. 2019;53:655–62.

    Article  CAS  Google Scholar 

  5. Bahtiyar MO, Copel JA. Cardiac changes in the intrauterine growth-restricted fetus. Semin Perinatol. 2008;32:190–3.

    Article  PubMed  Google Scholar 

  6. Yildirim A, Ozgen F, Ucar B, Alatas O, Tekin N, Kilic Z. The diagnostic value of troponin T level in the determination of cardiac damage in perinatal asphyxia newborns. Fetal Pediatr Pathol. 2016;35:29–36.

    Article  CAS  PubMed  Google Scholar 

  7. Ker JA, Soma-Pillay P. NT-proBNP: when is it useful in obstetric medicine? Obstetric Medicine. 2018;11:3–5.

    Article  PubMed  Google Scholar 

  8. Kocylowski RD, Dubiel M, Gudmundsson S, Sieg I, Fritzer E, Alkasi Ö, et al. Biochemical tissue-specific injury markers of the heart and brain in postpartum cord blood. Am J Obstet Gynecol. 2009;200:273.e1-273.e25.

    Article  PubMed  Google Scholar 

  9. Yarcı Gursoy A, Caglar GS, Demirtas S. Ischemia modified albumin in perinatology. Eur J Obstet Gynecol Reprod Biol. 2017;210:182–8.

    Article  PubMed  Google Scholar 

  10. Awadh AMA, Prefumo F, Bland JM, Carvalho JS. Assessment of the intraobserver variability in the measurement of fetal cardiothoracic ratio using ellipse and diameter methods. Ultrasound Obstet Gynecol. 2006;28:53–6.

    Article  CAS  PubMed  Google Scholar 

  11. DeVore GR, Klas B, Satou G, Sklansky M. 24-segment sphericity index: a new technique to evaluate fetal cardiac diastolic shape. Ultrasound in Obstetrics & Gynecology : The Official J Int Soc Ultrasound in Obstetrics Gynecol. 2018;51:650–8.

    Article  CAS  Google Scholar 

  12. García-Otero L, Gómez O, Rodriguez-López M, Torres X, Soveral I, Sepúlveda-Martínez Á, et al. Nomograms of fetal cardiac dimensions at 18–41 weeks of gestation. Fetal Diagn Ther. 2020;47:387–98.

    Article  PubMed  Google Scholar 

  13. Patey O, Gatzoulis MA, Thilaganathan B, Carvalho JS. Perinatal changes in fetal ventricular geometry, myocardial performance, and cardiac function in normal term pregnancies. J Am Soc Echocard : Official Publication Am Soc of Echocardio. 2017;30:485-492.e5.

    Article  Google Scholar 

  14. Cruz-Lemini M, Crispi F, Valenzuela-Alcaraz B, Figueras F, Sitges M, Gómez O, et al. Value of annular M-mode displacement vs tissue Doppler velocities to assess cardiac function in intrauterine growth restriction. Ultrasound in Obstetrics & Gynecology : The Official J Int Soc Ultrasound Obstetrics Gynecol. 2013;42:175–81.

    Article  CAS  Google Scholar 

  15. Crispi F, Crovetto F, Gratacos E. Intrauterine growth restriction and later cardiovascular function. Early Human Dev. 2018;126:23–7.

    Article  Google Scholar 

  16. Rizzo G, Mattioli C, Mappa I, Bitsadze V, Khizroeva J, Słodki M, et al. Hemodynamic factors associated with fetal cardiac remodeling in late fetal growth restriction: a prospective study. J Perinat Med. 2019;47:683–8.

    Article  PubMed  Google Scholar 

  17. Pérez-Cruz M, Cruz-Lemini M, Fernández MT, Parra JA, Bartrons J, Gõmez-Roig MD, et al. Fetal cardiac function in late-onset intrauterine growth restriction vs small-for-gestational age, as defined by estimated fetal weight, cerebroplacental ratio and uterine artery Doppler. Ultrasound in Obstetrics & Gynecology : The Official J Int Soc Ultrasound Obstetrics Gynecol. 2015;46:465–71.

    Article  Google Scholar 

  18. Channing A, Szwast A, Natarajan S, Degenhardt K, Tian Z, Rychik J. Maternal hyperoxygenation improves left heart filling in fetuses with atrial septal aneurysm causing impediment to left ventricular inflow. Ultrasound Obstet Gynecol 2015;45:664–669.

  19. Zhang L, Han J, Zhang N, Li Z, Wang J, Xuan Y, et al. Assessment of fetal modified myocardial performance index in early-onset and late-onset fetal growth restriction. Echocardiography (Mount Kisco, NY). 2019;36:1159–64.

    Article  Google Scholar 

  20. Nguyen TTN, Kotani T, Imai K, Ushida T, Moriyama Y, Kobayashi T, et al. Assessment of myocardial performance index in late-onset fetal growth restriction. Nagoya J Med Sci. 2021;83:259–68.

    PubMed  PubMed Central  Google Scholar 

  21. Guo XF, Li YL, Zhao BW. Annular plane systolic excursion Z-scores in evaluation of heart systolic function of fetus with heart failure. J Matern Fetal Neonatal Med 2022;35(25):5301–5307.

  22. Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Intern Med. 2007;262:651–8.

    Article  CAS  PubMed  Google Scholar 

  23. Katrukha IA. Human cardiac troponin complex. Structure and functions Biochemistry (Moscow). 2013;78:1447–65.

    Article  CAS  PubMed  Google Scholar 

  24. Gaggin HK, Januzzi JL. Biomarkers and diagnostics in heart failure. Biochem Biophys Acta. 2013;1832:2442–50.

    CAS  PubMed  Google Scholar 

  25. Garofoli F, Mannarino S, Montanari L, Cerbo R, Tzialla C, Mazzucchelli I, et al. Variation of B-type natriuretic peptide concentrations and intrauterine growth restriction: mother, fetus and newborn. J Biol Regul Homeost Agents. 2012;26:733–9.

    CAS  PubMed  Google Scholar 

  26. Mannarino S, Ciardelli L, Garofoli F, Perotti G, Mongini E, Damiano S, et al. Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns. Early Human Dev. 2009;85:13–7.

    Article  CAS  Google Scholar 

  27. Sari N, Ede H, Engin-Ustun Y, Göçmen AY, Çaǧlayan EK. Hyperemesis gravidarum is associated with increased maternal serum ischemia-modified albumin. J Perinat Med. 2017;45:421–5.

    Article  CAS  PubMed  Google Scholar 

  28. Dahiya K, Kulshrestha MR, Bansal P, Ghalaut VS, Kulshrestha R, Dahiya P, et al. Evaluation of cord blood ischemia modified albumin in normal pregnancies and pre-eclampsia. Hypertens Pregnancy. 2015;34:204–8.

    Article  CAS  PubMed  Google Scholar 

  29. Tayyar AT, Kozalı S, Yetkin Yildirim G, Karakus R, Yuksel IT, Erel O, et al. Role of ischemia-modified albumin in the evaluation of oxidative stress in intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2019;32:3836–40.

    Article  CAS  PubMed  Google Scholar 

  30. Andıç E, Karaman E, Kolusarı A, Çokluk E. Association of cord blood ischemia-modified albumin level with abnormal foetal Doppler parameters in intrauterine growth-restricted foetuses. J Matern Fetal Neonatal Med. 2021;34:1–6.

    Article  PubMed  Google Scholar 

  31. Lacovidou N, Briana DD, Boutsikou M, Liosi S, Baka S, Boutsikou T, et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediators Inflamm 2008;2008:523081

Download references

Funding

This study was funded by Gazi University Research Committee (Project No: 6478/2021; no involvement in study design, collection, analysis, and writing the report).

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Medicine, Gazi University, Ankara, Turkey

    Ezgi Turgut, Halis Özdemir, Merih Bayram & Deniz Karcaaltıncaba

  2. Department of Medical Biochemistry, Faculty of Medicine, Gazi University, Ankara, Turkey

    Belkıs Narlı & Canan Yılmaz

Authors
  1. Ezgi Turgut
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halis Özdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Belkıs Narlı
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Canan Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Merih Bayram
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deniz Karcaaltıncaba
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HÖ, BN, and ET searched, excluded, or included and rated the quality of the studies. DK, MB, CY, and ET interpreted the results and contributed to the writing process. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Ezgi Turgut.

Ethics declarations

Ethics approval

Gazi University Faculty of Medicine Clinical Research Ethics Committee with the decision number 25901600–604.01.01–17 ethics committee decision no: 439.

Consent to participate

Written consent was obtained from patients.

Consent for publication

All patients have signed consent for publication in the study protocol.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Turgut, E., Özdemir, H., Narlı, B. et al. Umbilical Cord Blood Biochemical Cardiac Markers and Fetal Cardiac Function in Cases of IUGR. SN Compr. Clin. Med. 5, 27 (2023). https://doi.org/10.1007/s42399-022-01370-3

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s42399-022-01370-3

Keywords

Search

Navigation